ART with long-term effects without immunosuppression

Published Date: 02 Mar 2023

The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Reversing the toxic relationship with high doses of chemotherapy in oncology.

2.

For elderly, unfit patients, the all-oral AML regimen shows promise.

3.

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.

4.

Long-term study links chronic conditions in midlife to higher cancer risk and mortality

5.

The risk of cancer is decreased by following international health recommendations.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot